2-(2-Chloroethyl)-1-methylpiperidine hydrochloride, 1g

4-FLUORO-2-DIFLUOROMETHOXYNITROBENZENE, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-5, 60 m, 0,32 mm, 0,10 µm, 1 pièce(s)

(2S)-3-[tert-Butoxycarbonyl(isopropyl)amino]-2-(4-chlorophenyl)propanoic acid, 95%, 5g

N-hexadecyltrimethylammoniumhexafluorophosphate, 97%, 5g

2-Methyl-5-(4-methylpiperazin-1-yl)aniline, 95.0%, 250mg

(3-Isopropyl-[1,2,4]oxadiazol-5-ylmethyl)-carbamic acid tert-butyl ester, 95.0%, 1g

7-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95.0%, 250mg

N-Methyl-D-alanyl-4-fluoro-D-phenylalanine phenylmethyl ester hydrochloride, 95.0%, 1g

2-Amino-4-methyl-thiophene-3-carboxylic acid ethyl ester, 98.0%, 100g

SRC KINASE INHIBITOR I, 95%, 1g

3-Bromo-5-(trifluoromethoxy)benzaldehyde, 95.0%, 100g

9,9-DIMETHYL-10-PHENYL-9,10-DIHYDROACRIDINE, 98%, 250mg